Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]

Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether drug pressure...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Palmer M. Netongo, Akindeh M. Nji, Peter Thelma N. Niba, Innocent M. Ali, Randolph Ngwafor, Calvino F. Tah, Germaine Ekoyol, William D. Nana, Jude D. Bigoga, Dorothy F. Ashu, Wilfried F. Mbacham, Christopher B. Tume, Pacome V. K. Tchuenkam, Jean Paul K. Chedjou, Lesley N. Ngum
Format:	Artigo
Jezik:	Inglês
Izdano:	Wellcome 2024-06-01
Serija:	Wellcome Open Research
Teme:	sulfadoxine–pyrimethamine drug resistance plasmodium falciparum chemoprevention Pfdhps Cameroon eng
Online dostop:	https://wellcomeopenresearch.org/articles/9-323/v1
Oznake:	Označite Brez oznak, prvi označite!